Figure 2From: Renal function during rofecoxib therapy in patients with metastatic cancer: retrospective analysis of a prospective phase II trialChange of serum creatinine concentrations after end of therapy. Decrease of mean serum creatinine concentrations ± SEM after end of therapy with rofecoxib compared to the last day of treatment. *: p < 0.05.Back to article page